That would be assuming facts not in evidence…the fact is NNVC does not have enough money to complete drug trials….and nobody knows if that money will be made available via a partnership….or dilution to shareholders….presuming this doubtful drug with a pretentious name even passes said trials……lot of assumption here……stock price says otherwise.
Market Data 
Markets 
AI
